| 10/11/21 | 13:49:45 | 10 Nov 2021 | | Holding(s) in Company | RNS |
| 10/11/21 | 11:31:37 | 10 Nov 2021 | | Net Asset Value(s) | RNS |
| 09/11/21 | 12:30:53 | 9 Nov 2021 | | Net Asset Value(s) | RNS |
| 08/11/21 | 13:01:47 | 8 Nov 2021 | | Net Asset Value(s) | RNS |
| 05/11/21 | 11:33:09 | 5 Nov 2021 | | Net Asset Value(s) | RNS |
| 04/11/21 | 12:39:34 | 4 Nov 2021 | | Net Asset Value(s) | RNS |
| 03/11/21 | 11:48:49 | 3 Nov 2021 | | Net Asset Value(s) | RNS |
| 02/11/21 | 12:59:17 | 2 Nov 2021 | | Net Asset Value(s) | RNS |
| 01/11/21 | 15:38:20 | 1 Nov 2021 | | Move to Daily Pricing | RNS |
| 15/10/21 | 11:54:16 | 15 Oct 2021 | | Holding(s) in Company | RNS |
| 08/10/21 | 16:40:59 | 8 Oct 2021 | | Second Price Monitoring Extn | RNS |
| 08/10/21 | 16:36:04 | 8 Oct 2021 | | Price Monitoring Extension | RNS |
| 30/09/21 | 10:09:30 | 30 Sept 2021 | | Oxford Nanopore Completes IPO | RNS |
| 21/09/21 | 07:00:07 | 21 Sept 2021 | | Half-year Report | RNS |
| 16/09/21 | 09:14:06 | 16 Sept 2021 | | Oxford Nanopore Files Notice of Intention to Float | RNS |
| 10/09/21 | 14:22:24 | 10 Sept 2021 | | Oxford Nanopore expected intention to float | RNS |
| 25/08/21 | 07:00:03 | 25 Aug 2021 | | Block listing Interim Review | RNS |
| 09/08/21 | 07:00:07 | 9 Aug 2021 | | Investment in Revolut | RNS |
| 21/06/21 | 07:00:07 | 21 Jun 2021 | | NeoGenomics completes Inivata acquisition | RNS |
| 04/06/21 | 17:25:51 | 4 Jun 2021 | | AGM Results | RNS |
| 04/06/21 | 17:24:36 | 4 Jun 2021 | | Directorate Change | RNS |
| 27/05/21 | 07:00:09 | 27 May 2021 | | Announcement of NAV | RNS |
| 25/05/21 | 12:00:08 | 25 May 2021 | | Investment in Tessian | RNS |
| 06/05/21 | 16:56:51 | 6 May 2021 | | Director/PDMR Shareholding | RNS |
| 05/05/21 | 12:57:36 | 5 May 2021 | | Valuation adjustment following fundraising by ONT | RNS |
| 05/05/21 | 07:00:08 | 5 May 2021 | | Inivata to be acquired by NeoGenomics | RNS |
| 05/05/21 | 07:00:05 | 5 May 2021 | | Athenex to acquire Kuur | RNS |
| 26/04/21 | 07:00:06 | 26 Apr 2021 | | Annual Financial Report | RNS |
| 09/04/21 | 07:00:01 | 9 Apr 2021 | | Sanofi completes Kymab acquisition | RNS |
| 07/04/21 | 15:32:48 | 7 Apr 2021 | | Unaudited Net Asset Value as at 31 December 2020 | RNS |
| 19/03/21 | 16:40:43 | 19 Mar 2021 | | Second Price Monitoring Extn | RNS |
| 19/03/21 | 16:35:29 | 19 Mar 2021 | | Price Monitoring Extension | RNS |
| 15/03/21 | 07:00:06 | 15 Mar 2021 | | Completion of sale of assets to Rosetta Capital | RNS |
| 26/02/21 | 10:00:07 | 26 Feb 2021 | | Directorate Change | RNS |
| 25/02/21 | 07:00:08 | 25 Feb 2021 | | Block Listing Interim Review | RNS |
| 05/02/21 | 16:45:13 | 5 Feb 2021 | | Immunocore Prices NASDAQ IPO | RNS |
| 01/02/21 | 12:17:25 | 1 Feb 2021 | | Director/PDMR Shareholding | RNS |
| 01/02/21 | 11:14:41 | 1 Feb 2021 | | Director/PDMR Shareholding | RNS |
| 29/01/21 | 18:00:17 | 29 Jan 2021 | | Director/PDMR Shareholding | RNS |
| 27/01/21 | 07:00:02 | 27 Jan 2021 | | Agreement for sale of assets | RNS |
| 14/01/21 | 07:00:07 | 14 Jan 2021 | | Extension of Credit Facility | RNS |
| 11/01/21 | 07:53:31 | 11 Jan 2021 | | Sanofi to acquire Kymab | RNS |
| 08/01/21 | 11:36:50 | 8 Jan 2021 | | Holding(s) in Company | RNS |
| 22/12/20 | 13:10:24 | 22 Dec 2020 | | Holding(s) in Company | RNS |
| 21/12/20 | 07:00:06 | 21 Dec 2020 | | Hambro Perks to acquire Ombu’s portfolio | RNS |
| 11/12/20 | 16:59:49 | 11 Dec 2020 | | Holding(s) in Company | RNS |
| 03/12/20 | 17:28:16 | 3 Dec 2020 | | Holding(s) in Company | RNS |
| 03/12/20 | 07:00:07 | 3 Dec 2020 | | Net Asset Value(s) | RNS |
| 27/11/20 | 16:36:10 | 27 Nov 2020 | | Price Monitoring Extension | RNS |
| 23/10/20 | 14:59:11 | 23 Oct 2020 | | Holding(s) in Company | RNS |
